Viewing Study NCT05173805


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:09 AM
Study NCT ID: NCT05173805
Status: UNKNOWN
Last Update Posted: 2023-07-18
First Post: 2021-12-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module